C. Boewer

A phase II trial of interferon α-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma

E. Thiel, W. Berdel, E. Kreuser, 1992 .

Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.

E. Thiel, P. Delmas, A. Sakalová, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study

L. Edler, M. Herold, A. Franke, 1995 .

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

D. Niederwieser, M. Herold, A. Franke, 2006, Journal of Cancer Research and Clinical Oncology.

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

A. Glasmacher, R. Andreesen, C. Junghanss, 2006, The Journal of antimicrobial chemotherapy.

Long-Term Results in Adult AML: Comparison of Postremission Chemotherapy vs. Autologous BMT vs. Allogeneic BMT

M. Stauch, R. Schubert, R. Rohrberg, 1996 .

Epidemiological study on the hepatotoxicity of occupational toluene exposure

C. Boewer, S. Nawka, G. Enderlein, 1988, International archives of occupational and environmental health.

A Multicenter Prospective Randomized Trial with Assessment of Quality of Life in Patients with Metastatic Colorectal Carcinoma Comparing Interferon α-2b and Folinic Acid as Modulators of 5-Fluorouracil

E. Thiel, E. Kreuser, K. Ridwelski, 1994 .

Interferon α2b and Fotemustine in Patients with Disseminated Melanoma

E. Bröcker, U. Kleeberg, L. Edler, 1995 .

Tolerance, safety, and kinetics of the new antineoplastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial

G. Sybrecht, W. Wurst, D. Ukena, 2004, Cancer Chemotherapy and Pharmacology.